Medical & Clinical Reviews

COVID-19, Brief Review on epidemiology, prevention and anti-viral drug of Unani medicines

WHO On 31^st December 2019 informed, cluster of cases of pneumonia of unknown etiology from Wuhan, China, later named as COVID-19 now a global pandemic, with contagious all over the globe. The concern raises as more than 60% of the cases are asymptomatic/presymptomatic carries as these peoples are more prone to spread the infection and for symptomatic and infected persons the targeted treatment has yet to be developed. It has been testified that traditional remedies may alleviate the symptoms of COVID-19. Unani Medicine is one of the world’s ancient medical system that has many preventive regimes with treatment for many diseases including infectious fevers. However, a major hitch is a privation of precise scientific approach. Many studies of the Unani dugs has been proven for various immunomodualtory potential and antiviral against many viruses the potential compounds from these drugs also has been targeted against specific viral activity, this article aims to explore these Unani drugs as these drugs might have potential effect in prevention or treatment for COVID-19, its substantiation can take us for translational research to prove its scientific evidence on prevention and management of COVID-19.

Author(s):

Abstract | Full-Text | PDF

Share this